Skip to main content

Home/ Cancer/ Group items tagged Curative

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
Matti Narkia

Curative Brachytherapy for Recurrent/Residual Tongue Cancer - Entrez PubMed - 0 views

www.ncbi.nlm.nih.gov/...query.fcgi

Curative Brachytherapy Recurrent Residual Tongue Cancer head neck medicine medline science study research peer-reviewed pubmed oncology radiation radiotherapy therapy treatment imported delicious

shared by Matti Narkia on 24 Feb 09 - No Cached
  • Matti Narkia on 24 Feb 09
     
    Ayukawa F, Shibuya H, Yoshimura RI, Watanabe H, Miura M. Curative Brachytherapy for Recurrent/Residual Tongue Cancer. Strahlenther Onkol. 2007 Mar;183(3):133-137. PMID: 17340071 [PubMed - as supplied by publisher]
Matti Narkia

Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agent... - 0 views

www.sciencedirect.com/science

2009 February study review cannabinoid agonists cannabinoid_agonists cannabinoids CB receptors cancer anti-cancer anticancer inflammation angiogenesis antiangiogenic nausea pain medline therapy treatment cannabis

shared by Matti Narkia on 21 Mar 09 - Cached
  • Matti Narkia on 21 Mar 09
     
    Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents. Pisanti S, Malfitano AM, Grimaldi C, Santoro A, Gazzerro P, Laezza C, Bifulco M. Best Pract Res Clin Endocrinol Metab. 2009 Feb;23(1):117-31. PMID: 19285265 doi:10.1016/j.beem.2009.02.001    
Matti Narkia

Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumul... - 0 views

www.jhep-elsevier.com/...abstract

2009 August study research clinical_trial humans patients liver cancer liver_cancer HCC nutrition vitamin_K vitamin_K2 menatetrenone ACE-I ACE inhibitor medline recurrence risk Angiotensin-converting enzyme VEGF angiogenesis antiangiogenic

shared by Matti Narkia on 07 Dec 09 - Cached
  • Matti Narkia on 07 Dec 09
     
    Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma. Yoshiji H, Noguchi R, Toyohara M, Ikenaka Y, Kitade M, Kaji K, Yamazaki M, Yamao J, Mitoro A, Sawai M, Yoshida M, Fujimoto M, Tsujimoto T, Kawaratani H, Uemura M, Fukui H. J Hepatol. 2009 Aug;51(2):315-21. Epub 2009 May 15. PMID: 19501932 CONCLUSIONS: The combination treatment of VK and ACE-I may suppress the cumulative recurrence of HCC after the curative therapy, at least partly through suppression of the VEGF-mediated neovascularization.
1 - 3 of 3
Showing 20▼ items per page